1CUI H F,YE J S,LIU A L,et al.Lipid microvesicles:on the four decades of liposome research[J].Adv Lip Bilay Liposomes,2006,4:1-48.
2MALAM Y,LOIZIDOU M,SEIFALIAN A M.Liposomes and nanoparticles:nanosized vehicles for drug delivery in cancer[J].Trends Pharmacological Sci,2009,30(11):592-599.
3KENWORTHY A K.Structure and phase behavior of lipid suspensions containing phospholipids with covalently attached poly(ethylene glycol)[J].Biophysical J,1995,68(5):1903-1920.
4KIM J Y,KIM J K,PARK J S,et al.The use of PEG ylated liposomes to prolong circulation lifetimes of tissue plasminogen activator[J].Biomaterials,2009,30(29):5751-5756.
5REGEN S L,SINGH M,SAMUEL N K P.Function-alized polymeric liposomes,efficient immobilization of alpha chymotrypsin[J].Biochem Biophys Res,1984,119(2):646-651.
6BUCKE W E.Surface modified amikacin liposomes:organ distribution and interaction with plasma proteins[J].J Drug Targeting,1997,5 (2):99.
8JEONG S Y,YI S L,LIM S K,et al.Enhancement of radiotherapeutic effectiveness by temperature-sensitive liposomal 1-methylxanthine[J].Int J Pharmaceutics,2009,372(1-2):132-139.
9WU X S,HOFFMAN A S,YAGER P.Conjugation of phosphatidylethanolamine to poly(N-isopropylacrylamide) for potential use in liposomal drug delivery systems[J].Polymer,1992,33(21):4659-4662.
10KIM J C,BAE S K,KIM J D.Temperature-sensitivity of liposomal lipid bilayers mixed with poly (N-isopropylacrylamide-co-acrylic acid)[J].J Biochem,1997,121 (1):15-19.
